Clinical Trial Update: Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a combination of hydroxychloroquine, capecitabine, oxaliplatin, and bevacizumab in metastatic colorectal cancer has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Hydroxychloroquine (hydroxychloroquine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-03-11